Jack Shostak, PhD

Associate Director
Duke Clinical Research Institute, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• Preliminary Results from HERO-together: A Post-emergency Use Authorization Observational Cohort Study to Evaluate the Safety of the Pfizer-BioNTech COVID-19 Vaccine in US Healthcare Workers and Community Members

  Sunday, August 28, 2022
  2:30 PM – 2:45 PM CEST